Genmab hit a record high after a cancer drug combination cut death risk by 50% in a late-stage trial.
Why Did ETSY, REPL, GMAB Stocks Surge To 52-Week Highs Today?
view original post
Genmab hit a record high after a cancer drug combination cut death risk by 50% in a late-stage trial.